<DOC>
	<DOCNO>NCT01463735</DOCNO>
	<brief_summary>Acanthocytes , also term spur cell , large erythrocyte cover spike-like projection associate severe hemolytic anemia . In advanced cirrhosis , acanthocyte may account 20 30 % red blood cell . Up 70 % cirrhotic patient display anemia hemoglobin level may fall 5 gr/L spur cell anemia . The true incidence spur cell cirrhosis know precisely may avoisinate 45 % , typically patient advance cirrhosis.The presence spur cell usually predict low survival rate . Vitamin E antioxidant compound component biological membrane help maintain integrity lipid bilayers . Vitamin E deficiency lead erythrocyte hemolysis , improve supplemental vitamin E. This study open label single arm phase II study cirrhotic patient treat 4 week Tocofersolan ( Vedrop ) , water-soluble derivative alpha-tocopherol , thus orally bio-available source vitamin E. The aim study determine effect tocofersolan red blood cell membrane lipid composition adult patient cirrhosis vitamin E deficiency . Secondary endpoint effect tocofersolan anemia , hemolysis acanthocytosis ; lipid peroxidation oxidative stress ; safety 4 week treatment 700 mg/day .</brief_summary>
	<brief_title>Vitamin E Supplement Patients With Cirrhosis Acanthocytosis</brief_title>
	<detailed_description>Background : Cirrhosis may complicate presence ascites , portosystemic collateral may eventually bleed give rise hepatic encephalopathy . Laboratory finding patient cirrhosis include alteration synthetic function well increase serum bilirubin . Liver diseases also associate hematologic complication alter red blood cell morphology . Up 70 % cirrhotic patient display anemia hemoglobin level may fall 5 gr/L spur cell anemia . Thrombocytopenia , leucopenia neutropenia also common . In patient cirrhosis , acanthocytes echinocytes report . Acanthocytes , also term spur cell , large erythrocyte cover spike-like projection associate severe hemolytic anemia . In advanced cirrhosis , acanthocyte may account 20 30 % red blood cell . The spiky morphology acanthocyte result abnormal surface area volume ratio alter membrane lipid composition . These change red blood cell membrane render cell prone destruction hemolysis . The true incidence spur cell cirrhosis know precisely may avoisinate 45 % , typically patient advance cirrhosis.The presence spur cell usually predict low survival rate . The liver susceptible organ oxidative-related cellular damage , low antioxidant , vitamin E , cirrhosis participate cellular membrane alteration . Vitamin E antioxidant compound component biological membrane help maintain integrity lipid bilayers . Vitamin E deficiency lead erythrocyte hemolysis , improve supplemental vitamin E. Tocofersolan ( Vedrop ) water-soluble derivative alpha-tocopherol , thus orally bio-available source vitamin E. Vitamin E supplementation appear safe liver disease provide histological benefit NASH . Aim endpoints I . To determine effect tocofersolan red blood cell membrane lipid composition adult patient cirrhosis vitamine E deficiency II . To determine effect vit E anemia , hemolysis acanthocytosis ; lipid peroxidation oxidative stress ; safety 4 week treatment 700 mg/day Duration : selection period : 1 week ; active treatment : 4 week ; follow-up period . 3 week . Evaluation time-points : baseline 4 week treatment Methodology/Design : phase II pilot trial 27 patient , single arm study</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Age &gt; 18 year old Cirrhosis ( histology , available , base clinical , biological radiological finding ) Total bilirubin &gt; 60 µmol/ L Anemia define hemoglobin &lt; 120 g/L Vitamin E deficiency define plasma level &lt; 23 µmol/L Inability unwillingness give write consent Parenteral nutrition Comedication Orlistat , Colestipol , anticoagulant Active alcohol consumption assess urine analysis Gastrointestinal bleeding within past 2 week Gastric bypass Moderate severe renal failure define creatinine clearance &lt; 60 ml/min Hypothyroidism define TSH &gt; 6 mU/L Diagnosis cancer upon inclusion study Any severe condition affect interfere normal conduct study Already participate another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Cirrhotic patient</keyword>
</DOC>